HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Norbert Mülleneisen Selected Research
Norbert Mülleneisen Research Topics
Disease
7
Hypersensitivity (Allergy)
03/2024 - 12/2018
5
COVID-19
11/2022 - 01/2020
2
Asthma (Bronchial Asthma)
03/2024 - 01/2017
2
Syphilis
04/2021 - 01/2021
1
Respiratory Sounds (Crackle)
03/2024
1
Fever (Fevers)
03/2024
1
Immediate Hypersensitivity
11/2022
1
Anaphylaxis (Anaphylactic Shock)
01/2021
1
Inflammation (Inflammations)
01/2021
1
Peanut Hypersensitivity (Peanut Allergy)
01/2021
1
Severe Acute Respiratory Syndrome
01/2021
1
Contact Dermatitis (Eczema, Contact)
01/2020
1
Drug Hypersensitivity (Drug Allergy)
01/2020
1
Aspergillosis
01/2017
1
Infections
01/2017
Drug/Important Bio-Agent (IBA)
5
Vaccines
IBA
11/2022 - 01/2021
3
Penicillins (Penicillin)
FDA Link
04/2021 - 01/2020
2
Anti-Bacterial Agents (Antibiotics)
IBA
03/2024 - 01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2024
1
Bronchodilator Agents (Bronchodilators)
IBA
03/2024
1
mRNA Vaccines
IBA
11/2022
1
Messenger RNA (mRNA)
IBA
11/2022
1
COVID-19 Vaccines
IBA
11/2022
1
BNT162 Vaccine
IBA
01/2021
1
Allergens
IBA
01/2021
1
Epinephrine (Adrenaline)
FDA Link
Generic
01/2021
1
beta-Lactams
IBA
01/2020
1
Cephalosporins (Cephalosporin Antibiotics)
IBA
01/2020
1
Monoclonal Antibodies
IBA
01/2020
1
beta Lactam Antibiotics
IBA
01/2020
Therapy/Procedure
3
Therapeutics
01/2021 - 01/2017
2
Immunotherapy
12/2018 - 01/2017
1
Emergency Treatment
01/2021
1
Drug Therapy (Chemotherapy)
01/2020